OMCL Butterfly Strategy
OMCL (Omnicell, Inc.), in the Healthcare sector, (Medical - Equipment & Services industry), listed on NASDAQ.
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
OMCL (Omnicell, Inc.) trades in the Healthcare sector, specifically Medical - Equipment & Services, with a market capitalization of approximately $1.70B, a trailing P/E of 43.39, a beta of 0.97 versus the broader market, a 52-week range of 29.06-55, average daily share volume of 682K, a public-listing history dating back to 2001, approximately 4K full-time employees. These structural characteristics shape how OMCL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.97 places OMCL roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 43.39 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a butterfly on OMCL?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
OMCL snapshot
As of August 14, 2026, spot at $37.09, ATM IV 43.00%, IV rank 2.87%, expected move 12.33%. The butterfly on OMCL below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this butterfly structure on OMCL specifically: OMCL IV at 43.00% is on the cheap side of its 1-year range, which favors premium-buying structures like a OMCL butterfly, with a market-implied 1-standard-deviation move of approximately 12.33% (roughly $4.57 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated OMCL expiries trade a higher absolute premium for lower per-day decay. Position sizing on OMCL should anchor to the underlying notional of $37.09 per share and to the trader's directional view on OMCL stock.
OMCL butterfly setup
The OMCL butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With OMCL at $37.09 on that close, the first option leg uses a $35.24 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed OMCL chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 OMCL shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $35.24 | N/A |
| Sell 2 | Call | $37.09 | N/A |
| Buy 1 | Call | $38.94 | N/A |
OMCL butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
OMCL butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on OMCL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on OMCL
Butterflies on OMCL are pinning bets - traders use them when they expect OMCL to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
OMCL thesis for this butterfly
The market-implied 1-standard-deviation range for OMCL extends from approximately $32.52 on the downside to $41.66 on the upside. A OMCL long call butterfly is a pinning play: it pays maximum at the middle strike if OMCL settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current OMCL IV rank near 2.87% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on OMCL at 43.00%. As a Healthcare name, OMCL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to OMCL-specific events.
OMCL butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. OMCL positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move OMCL alongside the broader basket even when OMCL-specific fundamentals are unchanged. Always rebuild the position from current OMCL chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on OMCL?
- A butterfly on OMCL is the butterfly strategy applied to OMCL (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With OMCL stock at $37.09 on the most recent close, the strikes shown on this page are snapped to the nearest listed OMCL chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are OMCL butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the OMCL butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 43.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a OMCL butterfly?
- The breakeven for the OMCL butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The OMCL market-implied 1-standard-deviation expected move in the same options snapshot is approximately 12.33%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on OMCL?
- Butterflies on OMCL are pinning bets - traders use them when they expect OMCL to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current OMCL implied volatility affect this butterfly?
- OMCL ATM IV is at 43.00% with IV rank near 2.87%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.